The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer

BACKGROUND: Pre-treatment tumour-associated lymphocytes (TILs) and stromal lymphocytes (SLs) are independent predictive markers of future pathological complete response (pCR) in HER2-positive breast cancer. Whilst studies have correlated baseline lymphocyte levels with subsequent pCR, few have studi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Breast Cancer Res Treat
Autors principals: Eustace, A. J., Madden, S. F., Fay, J., Collins, D. M., Kay, E. W., Sheehan, K. M., Furney, S., Moran, B., Fagan, A., Morris, P. G., Teiserskiene, A., Hill, A. D., Grogan, L., Walshe, J. M., Breathnach, O., Power, C., Duke, D., Egan, K., Gallagher, W. M., O’Donovan, N., Crown, J., Toomey, S., Hennessy, B. T.
Format: Artigo
Idioma:Inglês
Publicat: Springer US 2021
Matèries:
Preclinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8197702/
https://ncbi.nlm.nih.gov/pubmed/33983492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-021-06244-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars